← FDA DRUG APPROVALS

FDA ANDA · ANDA200156

ARMODAFINIL

Sponsor: WATSON LABS INC

APPLICATION
ANDA200156
TYPE
ANDA
ORIGINAL APPROVAL
2012-08-29
LATEST ACTION
2017-01-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval), Discontinued

Products

ARMODAFINILNone (Tentative Approval)
ARMODAFINIL 2500MG · TABLET · ORAL
ARMODAFINILNone (Tentative Approval)
ARMODAFINIL 150MG · TABLET · ORAL
ARMODAFINILNone (Tentative Approval)
ARMODAFINIL 50MG · TABLET · ORAL
ARMODAFINILDiscontinued
ARMODAFINIL 200MG · TABLET · ORAL
ARMODAFINILDiscontinued
ARMODAFINIL 100MG · TABLET · ORAL

Approval history

2017-01-25Labeling · Supplement 1 · standardAP
2012-08-29Not Applicable · OriginalTA
2012-08-29Not Applicable · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →